Alzheimer’s Disease Market Therapeutic Trends Forecast 2025–2034
Market Overview The global Alzheimer’s disease market is entering a transformative phase as scientific breakthroughs, regulatory momentum, and demographic shifts converge. Valued at US$ 6.37 billion in 2025 , the market is projected to reach US$ 12.41 billion by 2034 , expanding at a CAGR of 7.69% from 2025 to 2034 . This steady growth reflects rising disease prevalence, aging populations, and increasing demand for disease-modifying therapies. Alzheimer’s disease, a progressive neurodegenerative disorder, remains one of the most significant global health challenges. It impairs memory, cognitive ability, and daily functioning, placing a profound emotional and financial burden on patients, caregivers, and healthcare systems. The market encompasses pharmaceutical treatments, biologics, small-molecule drugs, diagnostic technologies, clinical research services, and post-marketing patient support programs. The scope of the Alzheimer’s disease market extend...